Rare-Disease-Drug-Surge-Requires-Comprehensive-Compassionate-Case-Management
By Marcus A. Banks NATIONAL HARBOR, Md.—Almost 40% of drug licensing applications submitted to the FDA are for orphan drugs that treat rare ...
Read more at Specialty Pharmacy Continuum
